|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―Jan―07 |
Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients |
Alejandro J Gonzalez-Ochoa, Gyozo Szolnoky, Ana G Hernandez-Ibarra, Jawed Fareed |
2 |
[GO] |
2024―Nov―12 |
Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19 |
Takuya Iwamoto, Yuki Hatayama, Noriko Yamashita, Hitomi Ichikawa, Koji Kawamura |
3 |
[GO] |
2024―Nov―05 |
Frequency and Association of Polymorphisms in F2, F7, and PROS1 Coagulation Genes with Disease Severity in Coronavirus Disease 2019 |
Dalal Sulaiman Alshaya, Lama A. Alzamil, Alanoud S. Alghamdi, Lolwah S. Alshammari, Saltana A. Alhowaiti, Marie Fe F. Bohol, et al. (+6) Esra’a Abudouleh, Fatimah Alhamlan, Arwa A. Al-Qahtani, Amal Al Hazzani, Tarek Owaidah, Ahmed A. Al-Qahtani |
4 |
[GO] |
2024―Jun―04 |
What Is the Impact of Baseline Inflammatory and Hemostatic Indicators with the Risk of Mortality in Severe Inpatients with COVID-19: A Retrospective Study |
Huiqi Zhu, Yeping Li, Hua Su, Chao Yan, Wanghao Xin, Kejing Ying |
5 |
[GO] |
2024―Mar―29 |
Sex Differences and Clinical Outcomes of Patients with Coronavirus Disease 2019 Infection and Cerebral Venous Sinus Thrombosis: A Systematic Review |
Saleh A. Algarni, Naif S. ALGhasab, Mohammed S. Alharbi, Anas Albarrak, Ahmad A. Alanezi, Hamdan M. Al Shehri |
6 |
[GO] |
2023―Dec―15 |
Impact of Concomitant Thrombotic Thrombocytopenic Purpura on COVID-19 Mortality and Morbidity: A Nationwide Inpatient Sample Analysis |
Ali Jaan, Zouina Sarfraz, Farhan Khalid, Junaid Anwar |
7 |
[GO] |
2023―Dec―11 |
The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study |
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Ramesh Vishwakarma, Mashael AlFaifi, et al. (+14) Samiah Alsohimi, Aljoharah Alrayes, Sara Albishi, Reem Alqahtani, Mai Alalawi, Ibrahim Al Sulaihim, Thamer A. Alanazi, Rahaf A. Alqahtani, Alaa Almagthali, Shahamah Jomah, Areej Alshlowi, Tahani R. Alshammari, Shahad S. Alzahrani, Marwa I. Abdulqader |
8 |
[GO] |
2023―Oct―30 |
Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the “ACO-VID” Registry |
Juan José Cerezo Manchado, Teodoro Iturbe Hernández, María del Carmen Martínez Pacheco, Ignacio Gil Ortega, Desirée Campoy, Tania Canals Pernas, et al. (+6) Laia Martinez Serra, Katia Jessica Flores Aparco, Cesar Andres Velasquez Escandon, Luis García de Guadiana-Romualdo, Antonio Martinez Frances, Pavel Olivera |
9 |
[GO] |
2023―Aug―07 |
Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis |
Awatif Hafiz, Hadeel Alkofide, Khalid Al Sulaiman, Hala Joharji, Sarah Aljohani, Khadijah A. Sarkhi, et al. (+5) Reem Alharbi, Ghazwa B. Korayem, Mashael AlFaifi, Samiah Alsohimi, Ohoud Aljuhani |
10 |
[GO] |
2023―Jul―05 |
Mean Platelet Volume may not be an Indicator of the Risk of Venous Thrombosis in COVID-19 Patients |
Cengiz Beyan, Esin Beyan |
11 |
[GO] |
2023―Jun―16 |
Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study |
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Lina I. Alnajjar, Ali F. Altebainawi, Mashael AlFaifi, et al. (+19) Ramesh Vishwakarma, Abeer A. Alenazi, Mai Alalawi, Abdulrahman Alissa, Yazed S. Alsowaida, Samiah Alsohimi, Alaa Almagthali, Saeed M. Alay, Noora Altaher, Mohammed G. Alamri, Dalal Alangari, Amer Alzahrani, Habeeb Ibrahim Abdul Razack, Jwael Alhamoud, Abdulrahman Alshaya, Jawaher Gramish, Kholoud Al Aamer, Alawi S. Alsaeedi, Ghassan Alghamdi |
12 |
[GO] |
2023―Jun―07 |
Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation |
Pável Olivera, César Velásquez-Escandón, Desirée Campoy, Katia Flores, Tania Canals, Erik Johansson, et al. (+4) María José Herranz, Laia Martínez, Juan José Cerezo-Manchado, Ramón Salinas |
13 |
[GO] |
2023―May―25 |
Lymphocytes, Mean Platelet Volume, and Albumin in Critically Ill COVID-19 Patients with Venous Thromboembolism |
Rundan Duan, Qihong Ni, Yinan Li, Mingli Zhu, Wen Li, Peng Wang, et al. (+5) Kai Yuan, Philipp von Hundelshausen, Jingpu Zhu, Lan Zhang, Lei Lv |
14 |
[GO] |
2023―May―19 |
Thrombosis Occurrence in COVID-19 Compared With Other Infectious Causes of ARDS: A Contemporary Cohort |
Andréa Coy-Canguçu, Gisele A. Locachevic, João Carlos S. Mariolano, Kaio Henrique De O. Soares, José Diogo Oliveira, Camila De Oliveira Vaz, et al. (+5) Gislaine Vieira-Damiani, Bruna Mazetto, Joyce Maria Annichino-Bizzacchi, Erich V. De Paula, Fernanda A. Orsi |
15 |
[GO] |
2023―May―03 |
Efficacy and Safety of Direct Oral Anticoagulants Compared With Heparin for Preventing Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis |
Yong Tian, Tao Pan, Xudong Wen, Guangyu Ao, Yihan Ma, Xiaoxiao Liu, et al. (+2) Rui Liu, Hongmei Ran |
16 |
[GO] |
2023―Feb―15 |
Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19 |
Raed Kensara, Ohoud Aljuhani, Ghazwa B Korayem, Hadeel Alkofide, Sumaya N Almohareb, Yousef S Alosaimi, et al. (+19) Ali F Altebainawi, Khalid Bin saleh, Norah Al Andas, Shmeylan Al Harbi, Abdullah F Al Harthi, Uhood Ashkan, Rema Alghamdi, Hisham A Badreldin, Awatif Hafiz, Mashael AlFaifi, Rahaf A Alqahtani, Ramesh Vishwakarma, Abeer A Alenazi, Mai Alalawi, Reem mahboob, Renad A Alfouzan, Layan B Al Tuhayni, Nouf Al Qahtani, Khalid Al Sulaiman |
17 |
[GO] |
2023―Feb―01 |
The Efficacy and Safety of Prolonged Oral Anticoagulation for the Prevention of Thromboembolic Events in Patients Recovered From COVID-19 1 Year After Hospital Discharge: The SARCOV-19 Prospective Registry |
Ghizlane El Aidouni, Amine Bouchlarhem, Houssam Bkiyar, Nabila Ismaili, Noha El Ouafi, Brahim Housni |
18 |
[GO] |
2023―Jan―03 |
Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis |
Forough Mehrabi, Melina Farshbafnadi, Nima Rezaei |
19 |
[GO] |
2022―Dec―27 |
Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) |
Daniel Aston, Martin Besser, Ben Goddard, Nicholas Maggs, Hassan Ahmed, Florian Falter |
20 |
[GO] |
2022―Dec―23 |
Correction of Anticoagulant Therapy in Patients with Severe COVID-19 Virus Infection Using a Thrombodynamics Coagulation Assay |
Tatiana S. Vuimo, Sergey V. Tsarenko, Elena V. Filimonova, Elena A. Seregina, Sergey S. Karamzin |
21 |
[GO] |
2022―Dec―14 |
The Impact of Prior Antithrombotic use on Thromboembolic Events in Patients with Cardiovascular Disease and Severe COVID-19 Infection |
Amine Bouchlarhem, Soumia Boulouiz, Ghizlane el Aidouni, Houssam Bkiyar, Zakaria Bazid, Nabila Ismaili, et al. (+2) Brahim Housni, Noha El Ouafi |
22 |
[GO] |
2022―Nov―17 |
Recent Findings on Platelet Activation, vWF Multimers and Other Thrombotic Biomarkers Associated with Critical COVID-19 |
Guadalupe Damián-Vázquez, Nallely García-Larragoiti, Alan Cano-Méndez, Patricia Guzmán-Cancino, Aidyl Tiznado-Leyva, Sandra López-Castaneda, Martha Eva Viveros-Sandoval |
23 |
[GO] |
2022―Nov―12 |
Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19 |
Keith Robinson, Laura L. Schott, Tom Matthews, Manu Tyagi, Vivek B. Ajmani, Nancy Sacco, Zhun Cao |
24 |
[GO] |
2022―Oct―26 |
In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin |
Moudhi Alroomi, Ahmad Alsaber, Bader Al-Bader, Farah Almutairi, Haya Malhas, Jiazhu Pan, et al. (+9) Kobalava D. Zhanna, Maryam Ramadhan, Mohammad Al Saleh, Mohammed Abdullah, Naser Alotaibi, Noor AlNasrallah, Rajesh Rajan, Soumoud Hussein, Wael Aboelhassan |
25 |
[GO] |
2022―Sep―29 |
Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection |
Suhyeon Woo, Bohyun Kim, Nam Hun Heo, Min-sun Kim, Young Ahn Yoon, Young-Jin Choi |
26 |
[GO] |
2022―Aug―23 |
Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States |
W. Frank Peacock, James M. Crawford, Yen-Wen (Cindy) Chen, Veronica Ashton, Alicia K. Campbell, Dejan Milentijevic, Alex C. Spyropoulos |
27 |
[GO] |
2022―Aug―09 |
D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent Validation |
Joseph R. Bledsoe, Daniel Knox, Ithan D. Peltan, Scott C. Woller, James F. Lloyd, Gregory L. Snow, et al. (+3) Benjamin D. Horne, Jean M. Connors, Jeffrey A. Kline |
28 |
[GO] |
2022―Aug―04 |
Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019 |
Adham Mohamed, Shelby M Shemanski, Mohamed O Saad, Jeannette Ploetz, Michelle M Haines, Andrew B Schlachter, Majdi S Hamarshi |
29 |
[GO] |
2022―Jul―29 |
Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients |
Francisco José López-Jaime, Ihosvany Fernández-Bello, Sandra Martín-Téllez, Alberto Doblas-Márquez, Yohannes Tesfay, Ignacio Márquez-Gómez, et al. (+3) José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Adrián Montaño |
30 |
[GO] |
2022―Jul―18 |
Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 Pandemic |
Thao Doan, Fabio Lievano, Linda Scarazzini, Kate Liebelt, Mark Jaradeh, Bulent Kantarcioglu, et al. (+2) Jawed Fareed, W. Keith Jones |
31 |
[GO] |
2022―Jun―29 |
Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19 |
Wei Xia, Yafeng Tan, Shengmei Hu, Chengbin Li, Tao Jiang |
32 |
[GO] |
2022―Jun―14 |
COVID-19 Infection in Patients with Comorbidities: Clinical and Immunological Insight |
Omnia El-Badawy, Nahla M. Elsherbiny, Doaa Abdeltawab, Doaa M. Magdy, Lamees M. Bakkar, Shimaa A. Hassan, et al. (+12) Elham A. Hassan, Ahmed M. Thabet, Ahmed M. Ashmawy, Ehab F. Moustafa, Wael A. Abbas, Ahmad Bahieldeen Ahmad, Amal Rayan, Khaled Saad, Amira Elhoufey, Hosni A. M. Hussein, Ali A. Thabet, Asmaa M. Zahran |
33 |
[GO] |
2022―Jun―06 |
Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study |
Shmeylan Al Harbi, Raed Kensara, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Abdullah Al Harthi, et al. (+18) Ramesh Vishwakarma, Alaa M. Alenazi, Abdulmajed Almutairi, Omar Alshaya, Sultan Alraddadi, Tareq Al Sulaiman, Latifah Aldakkan, Reem Mahboob, Kholoud Alaamer, Abdulrahman Alissa, Awatif Hafiz, Nada Aldhayyan, Sara Althewaibi, Farhan Alenezi, Nadeen Y. Alkhotani, Sara A. Alghamdi, Abeer A. Alenazi, Khalid Al Sulaiman |
34 |
[GO] |
2022―May―10 |
Correspondence on COVID-19 Vaccination and Acquired Haemophila A |
Pathum Sookaromdee, Viroj Wiwanitkit |
35 |
[GO] |
2022―Apr―05 |
Haemostatic Disarray Following COVID-19 Vaccine - a Case of Acquired Haemophila A |
Evelyn O'Shea, Orna Daly, Cleona Duggan, Maeve Crowley |
36 |
[GO] |
2022―Apr―01 |
Acute Myocardial Injury Assessed by High-Sensitive Cardiac Troponin Predicting Severe Outcomes and Death in Hospitalized Patients with COVID-19 Infection |
Falmata Laouan Brem, Miri Chaymae, Hammam Rasras, Manal Merbouh, Mohammed-Amine Bouazzaoui, Houssam Bkiyar, et al. (+5) Naima Abda, Bazid Zakaria, Nabila Ismaili, Brahim Housni, Noha El Ouafi |
37 |
[GO] |
2022―Mar―29 |
Rotational Thromboelastometry Profile among Critically ill COVID-19 Patients |
Indalecio Carboni Bisso, Iván Huespe, Eduardo Prado, Melina Garbarini, Marina Sol López, Luis Barrera, et al. (+3) Marcos Las Heras, Jorge Sinner, Marta Martinuzzo |
38 |
[GO] |
2022―Mar―25 |
Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients? |
Győző Szolnoky, Alejandro José González-Ochoa |
39 |
[GO] |
2022―Mar―21 |
Report of Low Incidence of Thrombosis with Early Prophylaxis in Hospitalized Patients with COVID-19 from Two Saudi Tertiary Centers |
Tarek Owaidah, Khalid Maghrabi, Feras Alfraih, Alfadil Haroon, Khawar Siddiqui, Randa Alnounou, et al. (+5) Hadeel AlOtair, Fatmah S Alqahtany, Mohannad Maghrabi, Mustafa Owaidah, Khalid AlSaleh |
40 |
[GO] |
2022―Mar―21 |
Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy? |
Felicio Savioli, Maurício Claro, Fernando Jose da Silva Ramos, Laerte Pastore |
41 |
[GO] |
2022―Mar―18 |
Improving Care of Older Patients with Hemophilia During COVID-19 Pandemic, Reducing the Risk of Venous Thrombosis with Home Exercises |
Ufuk Demirci, Elif G. Umit, Hande Ozdemir, Derya Demirbag Kabayel, Ahmet Muzaffer Demir |
42 |
[GO] |
2022―Mar―11 |
Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia |
Guillaume Roberge, Marc Carrier |
43 |
[GO] |
2022―Feb―15 |
An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations |
Bulent Kantarcioglu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio Lievano, et al. (+5) Mark Ligocki, Walter Jeske, Cafer Adiguzel, Grigoris T. Gerotziafas, Jawed Fareed |
44 |
[GO] |
2022―Feb―02 |
Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination |
Mona Al-Ahmad, Mona Al Rasheed, Neveen Shalaby, Tito Rodriguez-Bouza, Lulwa Altourah |
45 |
[GO] |
2022―Jan―24 |
Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review |
Michael Joseph Cryer, Serdar Farhan, Christoph C. Kaufmann, Bernhard Jäger, Aakash Garg, Prakash Krishnan, et al. (+2) Roxana Mehran, Kurt Huber |
46 |
[GO] |
2021―Dec―22 |
Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis |
Rostami Mehrdad, Khoshnegah Zahra, Hassan Mansouritorghabeh |
47 |
[GO] |
2021―Dec―15 |
Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) |
Susan Guy, Steve Kitchen, Michael Makris, Rhona M. Maclean, Giorgia Saccullo, Joost J Vanveen |
48 |
[GO] |
2021―Dec―15 |
Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis |
Tarinee Rungjirajittranon, Weerapat Owattanapanich, Nattawut Leelakanok, Natthaporn Sasijareonrat, Bundarika Suwanawiboon, Yingyong Chinthammitr, Theera Ruchutrakool |
49 |
[GO] |
2021―Dec―15 |
Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey |
Bulent Kantarcioglu, Krishan Patel, Joseph Lewis, Omer Iqbal, Fakiha Siddiqui, Nusrat Jabeen, et al. (+3) Atul R. Laddu, Charles A. Carter, Jawed Fareed |
50 |
[GO] |
2021―Dec―15 |
Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients |
Falmata Laouan Brem, Boudouh Asmae, Yassine Amane, Mohammed-Amine Bouazzaoui, Miri Chaymae, Hammam Rasras, et al. (+7) Siham Nasri, Naima Abda, Imane Skiker, Hatim Kouismi, Bazid Zakaria, Nabila Ismaili, Noha El Ouafi |
51 |
[GO] |
2021―Dec―15 |
Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review |
Usama Waqar, Shaheer Ahmed, Syed M.H.Ali Gardezi, Muhammad Sarmad Tahir, Zain ul Abidin, Ali Hussain, et al. (+2) Natasha Ali, Syed Faisal Mahmood |
52 |
[GO] |
2021―Nov―17 |
D-dimer, COVID-19 and Diabetes: A Correspondence |
Sora Yasri, Viroj Wiwanitkit |
53 |
[GO] |
2021―Nov―17 |
Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study |
Heidi Worth, Kasey Helmlinger, Renju Raj, Eric Heidel, Ronald Lands |
54 |
[GO] |
2021―Nov―15 |
Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19 |
Priyal Agarwal, Issa Haddad |
55 |
[GO] |
2021―Nov―10 |
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 |
Mark Klein, Vinh Dao, Fatima Khan |
56 |
[GO] |
2021―Nov―10 |
Thrombosis After Adenovirus-Vectored COVID-19 Vaccination: A Concern on Underlying Illness |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
57 |
[GO] |
2021―Oct―29 |
Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use |
Faruk Aydınyılmaz, Emrah Aksakal, Hilal Erken Pamukcu, Selim Aydemir, Remziye Doğan, İbrahim Saraç, et al. (+4) Sidar Şiyar Aydın, Kamuran Kalkan, Oktay Gülcü, İbrahim Halil Tanboğa |
58 |
[GO] |
2021―Oct―29 |
Low Incidence of Symptomatic Thrombotic Events in Adult Patients Hospitalized with Coronavirus 19: A Retrospective Cohort Study |
Marcelo G. Vallone, Carolina Vazquez, Fernando A. Chuliber, Verónica Privitera, Augusto Ferraris, Ramiro F. Cantarella, et al. (+4) María F. Indo, Diego M. Sanchez Thomas, Verónica A. Peuchot, Fernando J. Vazquez |
59 |
[GO] |
2021―Oct―26 |
COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis |
Muhammad Usman Hafeez, Maha Ikram, Zunaira Shafiq, Azza Sarfraz, Zouina Sarfraz, Vikash Jaiswal, et al. (+2) Muzna Sarfraz, Ivan Chérrez-Ojeda |
60 |
[GO] |
2021―Oct―25 |
Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum? |
Patrick Van Dreden, Jawed Fareed, Ismail Elalamy, Grigoris Gerotziafas |
61 |
[GO] |
2021―Oct―23 |
Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19 |
Zahra Elyaspour, Mohammad Javad Zibaeenezhad, Mahboobeh Razmkhah, Iman Razeghian-Jahromi |
62 |
[GO] |
2021―Oct―01 |
Anticoagulation for COVID-19 Patients: A Bird's-Eye View |
Firas Kreidieh, Sally Temraz |
63 |
[GO] |
2021―Sep―30 |
D-dimer Level and Diabetes in the COVID-19 Infection |
Chaymae Miri, Hajar Charii, Mohammed-Amine Bouazzaoui, Falmata Laouan Brem, Soumia boulouiz, Naima Abda, et al. (+4) Hatim Kouismi, Zakaria Bazid, Nabila Ismaili, Noha El Ouafi |
64 |
[GO] |
2021―Sep―30 |
Dengue After COVID-19 Vaccination: Possible and Might be Missed |
Amnuay Kebayoon, Viroj Wiwanitkit |
65 |
[GO] |
2021―Sep―20 |
Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination |
MA Haimei |
66 |
[GO] |
2021―Sep―09 |
Safety Interval From Increased Viscosity After COVID-19 Vaccination Among Persons With Cerebrovascular Problems |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
67 |
[GO] |
2021―Jun―30 |
Acetylsalicylic Acid and COVID-19 Prevention: A Comment |
Pathum Sookaromdee, Viroj Wiwanitkit |
68 |
[GO] |
2021―Jun―29 |
Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity |
Mehmet Gökhan Gönenli, Zeynep Komesli, Said İncir, Özlem Yalçın, Olga Meltem Akay |
69 |
[GO] |
2021―Jun―25 |
Clinical Features of COVID-19 Patients With Venous Thromboembolism |
Kai Liang, Ying Fu, Yi Kang, Huanzhang Shao, Jianxu Yang, Mingzhe Cui, Shuiting Zhai |
70 |
[GO] |
2021―Jun―18 |
Evaluation of Bleeding Rate and Time in Therapeutic Range in Patients Using Warfarin Before and During the COVID-19 Pandemic-Warfarin Treatment in COVID-19 |
Zeynep Yapan Emren, Oktay Şenöz, Ahmet Erseçgin, Sadık Volkan Emren |
71 |
[GO] |
2021―Jun―18 |
Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19 |
Beuy Joob, Viroj Wiwanitkit |
72 |
[GO] |
2021―Jun―02 |
An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination |
Bulent Kantarcioglu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, et al. (+7) Meharvan Singh, Fabio Lievano, Alfonso Tafur, Eduardo Ramacciotti, Grigoris T. Gerotziafas, Walter Jeske, Jawed Fareed |
73 |
[GO] |
2021―May―21 |
Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy |
Radu Crisan-Dabija, Alexandru Burlacu |
74 |
[GO] |
2021―May―20 |
The Meaning of D-Dimer value in Covid-19 |
Giulia Conte, Marco Cei, Isabella Evangelista, Alessandra Colombo, Josè Vitale, Antonino Mazzone, Nicola Mumoli |
75 |
[GO] |
2021―Apr―30 |
Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? |
Federico Cacciapuoti, Fulvio Cacciapuoti |
76 |
[GO] |
2021―Apr―30 |
Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression |
Haoting Zhan, Haizhen Chen, Chenxi Liu, Linlin Cheng, Songxin Yan, Haolong Li, Yongzhe Li |
77 |
[GO] |
2021―Apr―28 |
Blood Viscosity at the First Clinical Presentation in Fatal and Non-Fatal COVID-19: An Observation |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
78 |
[GO] |
2021―Apr―20 |
Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis |
Chatphatai Moonla, Darintr Sosothikul, Thita Chiasakul, Ponlapat Rojnuckarin, Noppacharn Uaprasert |
79 |
[GO] |
2021―Apr―09 |
Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection |
Sandra Lopez-Castaneda, Nallely García-Larragoiti, Alan Cano-Mendez, Kenia Blancas-Ayala, Guadalupe Damian-Vázquez, Ana Itzel Perez-Medina, et al. (+3) Luis David Chora-Hernández, Carlos Arean-Martínez, Martha Eva Viveros-Sandoval |
80 |
[GO] |
2021―Apr―08 |
ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study |
Joel G. Ray, Marian J. Vermeulen, Michael J. Schull, Alison L. Park |
81 |
[GO] |
2021―Apr―05 |
Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19 |
Luis O. Bobadilla-Rosado, Santiago Mier y Teran-Ellis, Gabriel Lopez-Pena, Javier E. Anaya-Ayala, Carlos A. Hinojosa |
82 |
[GO] |
2021―Mar―31 |
Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It |
Carlos A. Cañas, Felipe Cañas, Mario Bautista-Vargas, Fabio Bonilla-Abadía |
83 |
[GO] |
2021―Mar―30 |
Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic |
Serdar Farhan, Haroon Kamran, Birgit Vogel, Karan Garg, Ajit Rao, Navneet Narula, et al. (+9) Glenn Jacobowitz, Arthur Tarricone, Vishal Kapur, Peter Faries, Michael Marin, Jagat Narula, Robert Lookstein, Jeffrey W. Olin, Prakash Krishnan |
84 |
[GO] |
2021―Mar―24 |
Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose |
Zhenzhou Wang, Zhe Du, Xiujuan Zhao, Fuzheng Guo, Tianbing Wang, Fengxue Zhu |
85 |
[GO] |
2021―Feb―11 |
Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis |
Azza Sarfraz, Zouina Sarfraz, Aminah Abdul Razzack, Gaurav Patel, Muzna Sarfraz |
86 |
[GO] |
2021―Feb―10 |
Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection |
Harry N. Magnani |
87 |
[GO] |
2021―Jan―15 |
Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis |
Noppacharn Uaprasert, Chatphatai Moonla, Darintr Sosothikul, Ponlapat Rojnuckarin, Thita Chiasakul |
88 |
[GO] |
2020―Dec―29 |
Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis |
Chuanqi Cai, Yi Guo, Yun You, Ke Hu, Fei Cai, Mingxing Xie, et al. (+6) Lu Yang, Ken Ling, Dawei Ye, Sanjay Misra, Weici Wang, Yiqing Li |
89 |
[GO] |
2020―Oct―20 |
COVID-19 and Hypercoagulability: A Review |
Asim Kichloo, Kirk Dettloff, Michael Aljadah, Michael Albosta, Shakeel Jamal, Jagmeet Singh, et al. (+4) Farah Wani, Akshay Kumar, Srilakshmi Vallabhaneni, Muhammad Zia Khan |
90 |
[GO] |
2020―Oct―20 |
The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review |
Indra Wijaya, Rizky Andhika, Ian Huang |
91 |
[GO] |
2020―Oct―20 |
Prevalence and Risk Factors of Thromboembolism among Patients With Coronavirus Disease-19: A Systematic Review and Meta-Analysis |
Belayneh Kefale, Gobezie T. Tegegne, Amsalu Degu, Melaku Tadege, Desalegn Tesfa |
92 |
[GO] |
2020―Oct―15 |
Is Thrombophilic Genetic Profile Responsible for an Acute Ischemic Stroke in a COVID-19 Male Patient? |
Alexandru Burlacu, Bogdan Artene, Radu Crisan-Dabija, Iolanda Valentina Popa, Adrian Covic |
93 |
[GO] |
2020―Oct―08 |
A Retrospective Analysis of the Coagulation Dysfunction in COVID-19 Patients |
Xu Chen, Qinghua Wang, Min Xu, Chengbin Li |
94 |
[GO] |
2020―Sep―16 |
Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review |
Nicholas Kipshidze, Patrick Iversen, Thomas R. Porter, Nodar Kipshidze, Fakiha Siddiqui, George Dangas, Jawed Fareed |
95 |
[GO] |
2020―Sep―16 |
Anticoagulation in COVID-19: DDI Perspective |
Sajad Khiali, Taher Entezari-Maleki |
96 |
[GO] |
2020―Sep―04 |
Methodological Issues and Controversies in COVID-19 Coagulopathy: A Tale of Two Storms |
Samuel A Berkman, Victor F Tapson |
97 |
[GO] |
2020―Sep―02 |
Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic |
Faisal Alsayegh, Shaker A. Mousa |
98 |
[GO] |
2020―Aug―28 |
Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients |
Yuan Yu, Jie Tu, Bingxin Lei, Huaqing Shu, Xiaojing Zou, Ruiting Li, et al. (+3) Chaolin Huang, Yali Qu, You Shang |
99 |
[GO] |
2020―Aug―26 |
COVID-19, Antiphospholipid Syndrome and Thrombosis |
Sora Yasri, Viroj Wiwanitkit |
100 |
[GO] |
2020―Aug―26 |
Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events? |
Alexandru Burlacu, Simonetta Genovesi, Iolanda Valentina Popa, Radu Crisan-Dabija |
101 |
[GO] |
2020―Aug―21 |
Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic |
Kaveh Rezaei Bookani, Iva Minga, Manisha Chander, Ksenia Hankewych, Matthew Plassmeier, Alfonso Tafur |
102 |
[GO] |
2020―Aug―14 |
COVID-19 Associated Coagulopathy and Thrombotic Complications |
Zoubida Tazi Mezalek, Hajar Khibri, Wafaa Ammouri, Majdouline Bouaouad, Soukaina Haidour, Hicham Harmouche, et al. (+2) Mouna Maamar, Mohamed Adnaoui |
103 |
[GO] |
2020―Jul―31 |
COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response |
Apoorva Jayarangaiah, Pramod Theetha Kariyanna, Xiaoyi Chen, Amog Jayarangaiah, Abhishek Kumar |
104 |
[GO] |
2020―Jul―31 |
Coronavirus Disease and Acute Vascular Events |
Gundu H. R. Rao |
105 |
[GO] |
2020―Jul―29 |
Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan |
Jianpu Chen, Xiang Wang, Shutong Zhang, Bin Lin, Xiaoqing Wu, Yanfang Wang, et al. (+4) Xiaoqi Wang, Ming Yang, Jianqing Sun, Yuanliang Xie |
106 |
[GO] |
2020―Jul―29 |
Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications |
MA Haimei |
107 |
[GO] |
2020―Jul―24 |
Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19 |
Galit H. Frydman, Edward W. Boyer, Rosalynn M. Nazarian, Elizabeth M. Van Cott, Gregory Piazza |
108 |
[GO] |
2020―Jul―22 |
Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19? |
José A. Páramo |
109 |
[GO] |
2020―Jul―20 |
Viral Coagulopathy in Patients With COVID-19: Treatment and Care |
Nickolas Kipshidze, George Dangas, Christopher J. White, Nodar Kipshidze, Fakiha Siddiqui, Christopher R. Lattimer, et al. (+2) Charles A. Carter, Jawed Fareed |
110 |
[GO] |
2020―Jul―17 |
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation |
Wolfgang Miesbach, Michael Makris |
111 |
[GO] |
2020―Jul―13 |
Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium? |
Nil Guler, Fakiha Siddiqui, Jawed Fareed |
112 |
[GO] |
2020―Jul―10 |
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020 |
Eduardo Ramacciotti, Ariane Scarlatelli Macedo, Rodrigo Bruno Biagioni, Roberto Augusto Caffaro, Renato Delascio Lopes, João Carlos Guerra, et al. (+8) Fernanda Andrade Orsi, Marcos Areas Marques, Alfonso J. Tafur, Joseph A. Caprini, Andrew Nicolaides, Charles A. Carter, Cyrillo Carvalheiro Filho, Jawed Fareed |
113 |
[GO] |
2020―Jul―10 |
Reducing the Risk of Venous Thrombosis During Self-Isolation and COVID-19 Pandemic for Patients With Cancer: Focus on Home Exercises Prescription |
Ufuk Demirci, Hande Ozdemir, Derya Demirbag-Kabayel, Elif G. Umit, Ahmet Muzaffer Demir |
114 |
[GO] |
2020―Jul―03 |
COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets |
Erkan Cure, Medine Cumhur Cure |
115 |
[GO] |
2020―Apr―06 |
Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients |
Beuy Joob, Viroj Wiwanitkit |